Altimmune Inc (ALT)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: ALT Exchange: NMS


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2023-08-15 2023-08-15 B Purchase

Drutz David

Non-Executive Director
300 +1.0%
2.88
863 USD 		300 +1.0% 2.88 863 USD
2023-03-24 2023-03-24 B Purchase

Eisenstadt Richard I

Chief Financial Officer

Officer
10,000 +83.3%
4.31
43,140 USD 		10,000 +83.3% 4.31 43,140 USD
2023-03-27 2023-03-23 B Purchase

Drutz David

Non-Executive Director
9,000 +43.9%
4.27
38,430 USD 		9,000 +43.9% 4.27 38,430 USD
2023-03-23 2023-03-23 B Purchase

Harris Matthew Scott

Chief Medical Officer

Officer
10,000 +42.9%
4.22
42,200 USD 		10,000 +42.9% 4.22 42,200 USD
2022-12-22 2022-12-22 PS Planned sale

Pisano Wayne

Non-Executive Director
20,000 -70.2%
15.01
300,268 USD 		20,000 -70.2% 15.01 300,268 USD
2022-09-01 2022-08-31 PS Planned sale

Garg Vipin K

President and CEO

Executive Director
20,000 -7.8%
20.02
400,322 USD 		20,000 -7.8% 20.02 400,322 USD
2023-07-06 2022-08-12 S Sale

GILL JOHN

Non-Executive Director
2,714 -49.5%
15.00
40,710 USD 		2,714 -49.5% 15.00 40,710 USD
2022-08-12 2022-08-12 PS Planned sale

Garg Vipin K

President and CEO

Executive Director
15,000 -5.5%
15.06
225,890 USD 		15,000 -5.5% 15.06 225,890 USD
2022-07-05 2022-07-05 PS Planned sale

Roberts M Scot

Chief Scientific Officer

Officer
10,182 -55.1%
12.00
122,184 USD 		10,182 -55.1% 12.00 122,184 USD
2022-07-05 2022-07-01 PS Planned sale

Roberts M Scot

Chief Scientific Officer

Officer
26,982 -60.4%
12.00
323,784 USD 		26,982 -60.4% 12.00 323,784 USD
2022-06-28 2022-06-27 PS Planned sale

Roberts M Scot

Chief Scientific Officer

Officer
37,352 -67.8%
12.00
448,254 USD 		37,352 -67.8% 12.00 448,254 USD
2022-06-28 2022-06-27 PS Planned sale

Jorkasky Diane

Non-Executive Director
17,610 -100.0%
11.75
206,944 USD 		17,610 -100.0% 11.75 206,944 USD
2022-06-16 2022-06-15 B Purchase

Drutz David

Non-Executive Director
1,000 +5.3%
8.00
8,000 USD 		1,000 +5.3% 8.00 8,000 USD
2022-05-25 2022-05-24 B Purchase

Drutz David

Non-Executive Director
1,200 +6.7%
4.50
5,400 USD 		1,200 +6.7% 4.50 5,400 USD
2022-03-02 2022-02-28 PS Planned sale

Harris Matthew Scott

Chief Medical Officer

Officer
30,000 -72.2%
7.52
225,600 USD 		30,000 -72.2% 7.52 225,600 USD
2021-03-01 2021-03-01 PS Planned sale

Hodges Philip

Non-Executive Director
6,000 -40.7%
16.08
96,480 USD 		6,000 -40.7% 16.08 96,480 USD
2020-12-11 2020-12-10 B Purchase

Schafer Klaus

Non-Executive Director
2,000 +29.0%
11.99
23,980 USD 		2,000 +29.0% 11.99 23,980 USD
2020-12-02 2020-12-01 PS Planned sale

Hodges Philip

Non-Executive Director
1,227 -100.0%
13.54
16,614 USD 		1,227 -100.0% 13.54 16,614 USD
2020-12-02 2020-11-30 PS Planned sale

GILL JOHN

Non-Executive Director
8,425 -42.9%
11.92
100,426 USD 		8,425 -42.9% 11.92 100,426 USD
2020-12-02 2020-11-30 PS Planned sale

Hodges Philip

Non-Executive Director
2,500 -14.5%
12.00
30,000 USD 		2,500 -14.5% 12.00 30,000 USD
2020-11-13 2020-11-12 PS Planned sale

Schafer Klaus

Non-Executive Director
10,150 -59.5%
9.91
100,587 USD 		10,150 -59.5% 9.91 100,587 USD
2020-11-13 2020-11-12 PS Planned sale

Pisano Wayne

Non-Executive Director
10,352 -54.9%
9.90
102,485 USD 		10,352 -54.9% 9.90 102,485 USD
2020-11-13 2020-11-12 PS Planned sale

Harris Matthew Scott

Non-Executive Director
4,015 -49.7%
10.02
40,230 USD 		4,015 -49.7% 10.02 40,230 USD
2020-06-15 2020-06-15 B Purchase

Venrock Healthcare Capital Partners III, L.P.

Major owner
1,500,000 +50.0%
7.54
11,310,000 USD 		1,500,000 +50.0% 7.54 11,310,000 USD
2020-05-28 2020-05-28 B Purchase

Venrock Healthcare Capital Partners III, L.P.

Major owner
173,711 +6.1%
8.87
1,540,817 USD 		173,711 +6.1% 8.87 1,540,817 USD
2020-05-28 2020-05-28 B Purchase

Venrock Healthcare Capital Partners III, L.P.

Major owner
27,763 +1.0%
7.79
216,274 USD 		27,763 +1.0% 7.79 216,274 USD
2020-05-28 2020-05-27 B Purchase

Venrock Healthcare Capital Partners III, L.P.

Major owner
277,000 +11.0%
7.92
2,193,840 USD 		277,000 +11.0% 7.92 2,193,840 USD
2020-05-28 2020-05-27 B Purchase

Venrock Healthcare Capital Partners III, L.P.

Major owner
125,162 +5.2%
7.23
904,921 USD 		125,162 +5.2% 7.23 904,921 USD
2020-05-28 2020-05-26 B Purchase

Venrock Healthcare Capital Partners III, L.P.

Major owner
390,547 +19.5%
9.78
3,819,550 USD 		390,547 +19.5% 9.78 3,819,550 USD
2020-05-28 2020-05-26 B Purchase

Venrock Healthcare Capital Partners III, L.P.

Major owner
309,453 +18.2%
8.79
2,720,092 USD 		309,453 +18.2% 8.79 2,720,092 USD
2020-05-18 2020-05-15 S Sale

VELOCITY PHARMACEUTICAL HOLDINGS LLC

Major owner
30,622 -1.8%
4.65
142,392 USD 		30,622 -1.8% 4.65 142,392 USD
2020-05-18 2020-05-14 S Sale

VELOCITY PHARMACEUTICAL HOLDINGS LLC

Major owner
169,378 -9.0%
4.81
814,708 USD 		169,378 -9.0% 4.81 814,708 USD
2019-09-05 2019-09-05 B Purchase

Garg Vipin K

President and CEO

Executive Director
20,000 +6.2%
2.10
42,000 USD 		20,000 +6.2% 2.10 42,000 USD
2018-10-11 2018-10-09 B Purchase

Pisano Wayne

Non-Executive Director
2,000 +inf%
4.59
9,180 USD 		2,000 +inf% 4.59 9,180 USD
2018-05-29 2018-05-25 B Purchase

Enright William

President and CEO

Executive Director
1,300 +0.4%
0.51
660 USD 		1,300 +0.4% 0.51 660 USD
2018-01-03 2017-12-29 B Purchase

SAYARE MITCHEL

Non-Executive Director
5,100 +18.5%
1.95
9,963 USD 		5,100 +18.5% 1.95 9,963 USD
2018-01-02 2017-12-29 B Purchase

SCHAFFER DERACE L

Non-Executive Director
38,699 +7.0%
1.93
74,778 USD 		38,699 +7.0% 1.93 74,778 USD
2018-01-02 2017-12-28 B Purchase

SCHAFFER DERACE L

Non-Executive Director
58,711 +11.9%
1.92
112,672 USD 		58,711 +11.9% 1.92 112,672 USD
2017-12-27 2017-12-27 B Purchase

SCHAFFER DERACE L

27,706 +6.0%
1.77
49,040 USD 		27,706 +6.0% 1.77 49,040 USD
2017-12-27 2017-12-27 B Purchase

SCHAFFER DERACE L

50,000 +12.1%
1.76
88,170 USD 		50,000 +12.1% 1.76 88,170 USD
2017-12-27 2017-12-26 B Purchase

SCHAFFER DERACE L

51,442 +14.2%
1.81
93,269 USD 		51,442 +14.2% 1.81 93,269 USD
2017-12-27 2017-12-22 B Purchase

SCHAFFER DERACE L

17,982 +5.2%
1.61
28,877 USD 		17,982 +5.2% 1.61 28,877 USD
2017-12-08 2017-12-07 B Purchase

SCHAFFER DERACE L

7,639 +2.3%
1.74
13,308 USD 		7,639 +2.3% 1.74 13,308 USD
2017-12-08 2017-12-06 B Purchase

SCHAFFER DERACE L

16,106 +5.0%
1.80
28,996 USD 		16,106 +5.0% 1.80 28,996 USD
2017-12-05 2017-12-05 B Purchase

SCHAFFER DERACE L

13,495 +4.4%
1.78
23,987 USD 		13,495 +4.4% 1.78 23,987 USD
2017-12-05 2017-12-04 B Purchase

SCHAFFER DERACE L

7,300 +2.4%
1.81
13,195 USD 		7,300 +2.4% 1.81 13,195 USD
2017-12-05 2017-12-01 B Purchase

SCHAFFER DERACE L

5,215 +1.8%
1.80
9,405 USD 		5,215 +1.8% 1.80 9,405 USD
2017-11-30 2017-11-30 B Purchase

SCHAFFER DERACE L

12,978 +4.6%
1.84
23,816 USD 		12,978 +4.6% 1.84 23,816 USD
2017-11-30 2017-11-29 B Purchase

SCHAFFER DERACE L

7,942 +2.9%
1.94
15,377 USD 		7,942 +2.9% 1.94 15,377 USD
2017-11-30 2017-11-28 B Purchase

SCHAFFER DERACE L

12,395 +4.7%
1.97
24,445 USD 		12,395 +4.7% 1.97 24,445 USD
2017-11-27 2017-11-27 B Purchase

SCHAFFER DERACE L

10,042 +4.0%
2.00
20,060 USD 		10,042 +4.0% 2.00 20,060 USD
2017-11-27 2017-11-24 B Purchase

SCHAFFER DERACE L

6,505 +2.7%
2.02
13,162 USD 		6,505 +2.7% 2.02 13,162 USD
2017-11-27 2017-11-22 B Purchase

SCHAFFER DERACE L

5,261 +2.2%
2.10
11,061 USD 		5,261 +2.2% 2.10 11,061 USD
2017-11-21 2017-11-21 B Purchase

SCHAFFER DERACE L

7,236 +3.1%
2.06
14,905 USD 		7,236 +3.1% 2.06 14,905 USD
2017-11-21 2017-11-20 B Purchase

SCHAFFER DERACE L

4,800 +2.1%
2.07
9,958 USD 		4,800 +2.1% 2.07 9,958 USD
2017-11-21 2017-11-17 B Purchase

SCHAFFER DERACE L

6,295 +2.8%
2.12
13,352 USD 		6,295 +2.8% 2.12 13,352 USD
2017-08-28 2017-08-25 B Purchase

SCHAFFER DERACE L

50,000 +29.1%
2.25
112,390 USD 		50,000 +29.1% 2.25 112,390 USD
2017-08-28 2017-08-24 B Purchase

SCHAFFER DERACE L

17,326 +11.2%
2.24
38,892 USD 		17,326 +11.2% 2.24 38,892 USD
2017-08-24 2017-08-23 B Purchase

Drutz David

5,000 +19.4%
2.27
11,340 USD 		5,000 +19.4% 2.27 11,340 USD
2017-08-23 2017-08-23 B Purchase

SCHAFFER DERACE L

43,352 +39.0%
2.22
96,350 USD 		43,352 +39.0% 2.22 96,350 USD
2017-08-24 2017-08-22 B Purchase

Drutz David

5,000 +24.1%
2.15
10,758 USD 		5,000 +24.1% 2.15 10,758 USD
2017-08-23 2017-08-22 B Purchase

SCHAFFER DERACE L

5,958 +5.7%
2.10
12,519 USD 		5,958 +5.7% 2.10 12,519 USD
2017-08-23 2017-08-21 B Purchase

SCHAFFER DERACE L

690 +0.7%
2.02
1,395 USD 		690 +0.7% 2.02 1,395 USD
2018-02-23 2017-06-06 B Purchase

Roberts M Scot

Chief Scientific Officer

Officer
449 +inf%
4.42
1,985 USD 		449 +inf% 4.42 1,985 USD
2017-06-06 2017-06-02 B Purchase

GILL JOHN

1,000 +1.2%
4.34
4,344 USD 		1,000 +1.2% 4.34 4,344 USD
2016-12-09 2016-12-09 S Sale

PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.

Major owner
436,324 -6.2%
3.26
1,422,416 USD 		436,324 -6.2% 3.26 1,422,416 USD
2016-12-09 2016-12-08 S Sale

PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.

Major owner
440,479 -5.9%
3.25
1,431,557 USD 		440,479 -5.9% 3.25 1,431,557 USD
2016-12-09 2016-12-07 S Sale

PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.

Major owner
477,829 -6.0%
3.26
1,557,723 USD 		477,829 -6.0% 3.26 1,557,723 USD
2016-04-15 2016-04-13 PS Planned sale

RICHMAN ERIC I

Non-Executive Director
75,000 -29.8%
2.20
165,000 USD 		75,000 -29.8% 2.20 165,000 USD
2016-04-15 2016-04-13 PS Planned sale

RICHMAN ERIC I

Non-Executive Director
91,121 -34.0%
2.20
200,466 USD 		91,121 -34.0% 2.20 200,466 USD
2016-04-15 2016-04-13 PS Planned sale

RICHMAN ERIC I

Non-Executive Director
150,000 -45.9%
2.20
330,000 USD 		150,000 -45.9% 2.20 330,000 USD
2016-04-15 2016-04-13 PS Planned sale

RICHMAN ERIC I

Non-Executive Director
13,233 -7.0%
2.20
29,113 USD 		13,233 -7.0% 2.20 29,113 USD
2016-04-11 2016-04-08 PS Planned sale

RICHMAN ERIC I

Non-Executive Director
6,400 -3.5%
2.20
14,080 USD 		6,400 -3.5% 2.20 14,080 USD
2016-04-11 2016-04-07 PS Planned sale

RICHMAN ERIC I

Non-Executive Director
5,367 -2.9%
2.20
11,807 USD 		5,367 -2.9% 2.20 11,807 USD
2015-03-23 2015-03-19 B Purchase

St Peter Steven

Non-Executive Director
25,000 +inf%
1.65
41,213 USD 		25,000 +inf% 1.65 41,213 USD